Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...

Last month, the FDA declined to approve Sanofi’s tolebrutinib for a specific form of multiple sclerosis. In a recently ...

Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...

Exclusive: Scientists uncovered biological strands using artificial intelligence and hope discovery will revolutionise treatment ...

The faster patients can be diagnosed with multiple sclerosis the sooner they can begin taking the powerful medications that can prevent further brain damage. This fall, Lancet Neurology published new ...

Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...

Washington — President Trump underwent "advanced imaging" of his abdomen and cardiovascular system for "preventative" reasons, the White House said Monday, one day after the president told reporters ...

WASHINGTON (AP) — President Donald Trump said he’ll release the results of his MRI test that he received in October. “If you want to have it released, I’ll release it,” the Republican president said ...